万维提示：
1、投稿方式：在线投稿。
2、期刊网址：
https://home.liebertpub.com/publications/genetic-testing-and-molecular-biomarkers/18/overview
3、投稿网址：
https://mc.manuscriptcentral.com/genetic-testing
4、官网邮箱：如下。
5、期刊刊期：月刊，一年出版十二期。
2021年4月29日星期四
编辑邮箱【官网信息】
Editor-in-Chief
Garth D. Ehrlich, PhD, FAAAS
Drexel College of Medicine
245 North 15th St
Mail Stop 1013-A
Center for Genomic Sciences and Center for Advanced Microbial Processing
Institute for Molecular Medicine and Infectious Disease
Department of Microbiology and Immunology
Philadelphia, PA 19102 USA
215-762-1878
http://www.drexelmed.edu/Home/AboutOurFaculty/GarthEhrlich.aspx
garth.ehrlich@drexelmed.edu
Executive Assistant: Carol Hope
215.762.2959
Carol.Hope@DrexelMed.edu
Managing Editor
Sarah Fishkin
sfishkin@liebertpub.com
投稿须知【官网信息】
Information For Authors
Submitting Your Manuscript
Genetic Testing and Molecular Biomarkers publishes original articles on all aspects of human genetic testing, including prenatal diagnosis, risk assessment, clinical consequences of molecular genetics, results of population screens and targeted testing, methodologies, strategies and ethical and legal issues. Authors must obtain pre-approval from the Editor-in-Chief prior to submitting a meta-analysis. The Journal does not publish case reports.
Genetic Testing and Molecular Biomarkers carries a manuscript processing charge* of $49 USD upon submission of each new manuscript. Upon payment, you will be provided with a Manuscript Submission Code, and will be prompted to enter this information when uploading your files to our peer-review system. Please note: Securing a token does not automatically create an account in our peer-review system. If you do not already have an account, you will be asked to create one before you can begin your submission.
Submissions do not need to be completed at once. Submitting authors/agents may begin the submission process, save their work, and return to the site to complete the upload(s) at a later time. There is no limit on the number of times one can save their work and subsequently resume the submission. Doing so will not incur additional charges.
*The manuscript processing charge is independent of the editorial decision and is non-refundable.
ORCID IDs
The submitting author is required to complete the submission using an ORCID identifier. Please visit the ORCID website for more information, or to register. You must have an account in ScholarOne for Genetic Testing and Molecular Biomarkers before logging in with an ORCID identifier.
Manuscript Submission Site
Create an Account in ScholarOne
If you do not already have an account in ScholarOne for Genetic Testing and Molecular Biomarkers, you will need to create one. Once you create your account, you may log in to the system to begin your submission. Each listed author on a submission must either have an account, or have one created, in the submission system.
Use of English Language
All submissions must be in English. Appropriate use of English is a requirement for review and publication in Genetic Testing and Molecular Biomarkers. To support non-native speakers, Mary Ann Liebert, Inc., has partnered with Editage to provide language editing and translation services for a fee prior to official submission. To learn more about the services, please visit the Liebert Author Services website. Please note that employing the use of such services is not mandatory and using it, or any other language editing service, does not guarantee the acceptance of any paper. All submissions are subject to peer review.
AFTER SECURING YOUR SUBMISSION CODE, CLICK HERE TO SUBMIT YOUR MANUSCRIPT
See JOURNAL STANDARDS AND BEST PRACTICES STATEMENT
Check the Journal’s PEER REVIEW POLICIES
Manuscript Preparation
Determining Authorship
(See AUTHORSHIP DEFINITION AND RESPONSIBILITIES)
All authors, including the co-authors, should be responsible for a significant part of the manuscript. All authors and co-authors should have taken part in writing the manuscript, reviewing it, and revising its intellectual and technical content. Any author whose name appears on a manuscript assumes responsibility and accountability for the results.
Submission Process
CLICK HERE FOR ARTICLE TYPES AND WORD LIMITS
Please note: We are no longer accepting bioinformatic-only manuscripts. Therefore, if you wish to have your work considered for publication in GTMB, you must include laboratory-based validation studies of any genes (markers) you identify using in silico analyses.
All Original submissions must contain:
An Institutional Review Board (IRB) approval (or waiver) statement in the Methods section
Acknowledgments section (if applicable) after the Conclusion of the manuscript, followed by
An Author Contribution statement for each listed author, followed by
An Author Disclosure Statement for each author listed on a submission, even if there are no conflicts to disclose, followed by,
Funding statement(s), even if there is no funding information to declare.
See IRB APPROVALS, PATIENT CONSENT, & ETHICAL TREATMENT OF ANIMALS
See AUTHOR CONFIRMATION AND DISCLOSURE STATEMENTS
See FUNDING INFORMATION: COMPLIANCE AND STATEMENTS
All manuscripts must be prepared in accordance with the Uniform Requirements for Manuscripts Submitted to Biomedical Journals.
When submitting your manuscript for peer review, be prepared to:
Enter the full title of the manuscript
Enter the full names and institutional affiliations of ALL listed authors
Enter ALL listed authors' institutional email addresses
Identify the corresponding author
Enter a running (abbreviated) title of no more than 45 characters (including spaces).
Enter 3–6 keywords or phrases
Provide a structured abstract of no more than 250 words with distinct, labeled sections (e.g., Background, Objective, Methods, Results, Discussion and/or Conclusions).
Provide the names and email addresses of at least five potential preferred reviewers familiar with the field. Please make sure preferred reviewers are not from your university or institution or with whom you have collaborated. Anyone whom the author does not want to be considered should also be named as a non-preferred reviewer. Ultimate reviewer selection is at the Editor’s discretion.
Confirm that the material has not been published or submitted for publication elsewhere.
Create an Effective Title
Manuscript titles should be brief, contain key terms, and clearly identify the purpose of the work conducted
Manuscript titles should not exceed 15 -18 words. Exceptions can be made with the Editor’s approval
Manuscript titles should be direct and to the point. Remember that the journal has a global readership, so clear and concise non-vernacular language is most effective
Avoid the use of specific locations in the title
Do not use proprietary/trademarked names in the title
Do not use acronyms in the title unless they are universally recognized and accepted
NOTE: The title page of your submission must be included as part of your main text document (not as a separate file).
File Naming
All file names should be in English and contain only alphanumeric characters. Do not include spaces, symbols, special characters, dashes, dots, or underscores. Label each file with the first author's last name, followed by the content of the file (i.e.: SmithText; SmithTables; SmithFigureLegends; SmithFig1, etc.)
Important: Please upload individual files of all manuscript material as described herein — please do NOT upload a combined PDF file containing all material in your submission.
Preparation of Manuscript
Prepare text of manuscripts, figure legends, and tables in Microsoft Word, double spaced. The order of elements in each manuscript should be:
Title page (with full manuscript title, all contributing authors and their affiliations, a short running title, a denotation of the corresponding author with full contact information, including an institutional e-mail address, and a list of 3-6 keywords)
A separate page should include the full mailing address and contact information (telephone, fax, and e-mail address) for each author listed on the title page.
Abstract
Main text (do not embed figures or tables)
Conclusion (if applicable; as a separate paragraph, not as part of the Discussion section)
Acknowledgments (if applicable)
Authorship confirmation statement (see below)
Author(s’) disclosure statement(s) (see below)
Funding statement (see below)
References
Figure legends
Tables
Appendices (if applicable)
Supplemental Information (if applicable); NOTE: Supplemental Information will not be copyedited or typeset; it will be posted online as supplied.)
Manuscript Text
Maximum word count for original articles should not exceed 3,000 words. In general, the text should be organized under the headings: Introduction, Materials and Methods, Results, and Discussion. Number pages consecutively. The first author’s last name should appear on each page. Use only standard abbreviations, which can be found in the AMA’s Manual of Style for Authors & Editors or the Council of Biology Editors Style Manual, 10/e. At first usage, spell out terms and provide abbreviations in parentheses. Thereafter, use only the abbreviations. It is not necessary to spell out standard units of measure. Use generic names for drugs if possible. If you wish to use a proprietary drug name the first time it appears, use the generic name followed by the proprietary name, manufacturer, and location in parentheses.
References
Within the text, all references should be cited by authors and dates. Reference citations are not permitted in the abstract of a manuscript. If more than two authors are involved, use et al. (not italicized) after the first author’s name. If several articles by the same authors in the same year are cited in one sentence, use a lowercase letter designation to indicate the individual articles—i.e. (Dunn and Studier, 1973a, 1973b). Use the same designation in the reference list. In the References section, each item should be double-spaced and listed in alphabetical order at the end of the manuscript. Use journal abbreviations as provided by PubMed/Medline. List all authors when there are four or fewer. When there are more than four authors, list the first three, followed by et al. (not italicized). If references to personal communications or unpublished data are used, they are not to be in the list of references. They should be referred to in the text in parentheses: (AB Jones, personal communication). Include among the references any articles that have been accepted but have not yet published; identify the name of publication and add "In Press." If the reference has been published online, provide the DOI number in place of the page range.
Sample style for references:
Journal article:
Mo D, Li J, Peng L, et al. Genetic polymorphisms on 4q21.1 contributed to the risk of Hashimoto's thyroiditis. Genet Test Mol Biomarkers 2019;23:837-842.
Book:
Ahmad A, Gadgeel S, eds. Lung Cancer and Personalized Medicine: Current Knowledge and Therapies. Cham, Switzerland: Springer International Publishing, 2016.
Website:
Centers for Disease Control and Prevention. Genetic testing for hereditary breast and ovarian cancer. Page last reviewed: June 10, 2019. Available at https://www.cdc.gov/genomics/disease/breast_ovarian_cancer/testing.htm Accessed June 11, 2020.
Figure Legends
Figure legends should be uploaded as a separate Word file and double spaced. In the legend, provide explanations for any abbreviations, arrows, etc. that appear in the figure. If the illustration is taken from a copyrighted publication, permission must be secured, appropriate credit must be given in the legend, and a corresponding reference must appear in the reference section.
Tables
All tables should be prepared in one single Word file. Provide a title for each table. Cite tables in sequence in the text. Explain abbreviations used in the body of the table in footnotes. If the table is taken from a copyrighted publication, permission must be secured, appropriate credit must be given in the legend, and a corresponding reference must appear in the reference section.
Figures
Submission of high resolution .TIFF or .EPS figure files is strongly recommended.
Figures should not be embedded within the manuscript file.
Cite figures consecutively in text within parentheses.
A legend should be supplied for each figure and all legends numbered consecutively.
Images should not show the name of a patient or a manufacturer.
Do not include any illustrations as part of your text file.
Color publication of figures is encouraged, but the cost for color printing must be subsidized by the author(s). Color costs apply to all manuscripts, including those invited, unless the contributor has made prior arrangements with the Publisher. Alternatively, figures may be published in color in the online version of the journal, and black and white in the print version. This is an administrative cost and is instituted as two versions of the article must be prepared; one for print and one for online.
Correspondence Address
Following the references, provide the name and complete affiliation and institutional email address of the person to whom correspondence should be sent.
Manuscript Revisions
Processing charges and submission codes are NOT required for revisions to previously submitted manuscripts. To upload a revision of a manuscript, the submitting author should log in to their Author Center and click on “Revised Manuscripts in Draft.” All revised submissions will be required to meet all formatting conditions described herein. Submissions that do not satisfy these requirements will be un-submitted and returned to the submitting author for proper configuration.
Letters to the Editor
Genetic Testing and Molecular Biomarkers will consider Letters to the Editor commenting on the scientific content of an article published in the Journal. Letters should not exceed 500 words of text and 5 references. Letters submitted for publication must be original and must not be submitted to any other publication simultaneously.
For questions regarding manuscript submissions, contact our Author Services Division.
